Dose-proportional pharmacokinetic properties of GLA5PR GLARS-NF1 controlled-release pregabalin in healthy Korean volunteers: a randomized, open, single-dose, parallel study
Kwang-Hee Shin,1 Ji-Young Jeon,2 Kyungho Jang,2 Tae-Eun Kim,3 Min-Gul Kim2,4 1College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, Republic of Korea; 2Center for Clinical Pharmacology and Biomedical Research Institute, Chonbuk National University...
Main Authors: | Shin KH, Jeon JY, Jang K, Kim TE, Kim MG |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-10-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/dose-proportional-pharmacokinetic-properties-of-gla5pr-glars-nf1-contr-peer-reviewed-article-DDDT |
Similar Items
-
The use of deuterium-labeled gamma-aminobutyric (D6-GABA) to study uptake, translocation, and metabolism of exogenous GABA in plants
by: Faraj Hijaz, et al.
Published: (2020-02-01) -
In silico analysis of the inhibitory activities of GABA derivatives on 4-aminobutyrate transaminase
by: Hira Iftikhar, et al.
Published: (2017-02-01) -
Phenotype Expression Variability in Children with GABRB3 Heterozygous Mutations
by: Abdulhafeez M. Khair, et al.
Published: (2021-03-01) -
The effect of a finishing diet supplemented with γ-aminobutyric acids on carcass characteristics and meat quality of Hanwoo steers
by: Farouq Heidar Barido, et al.
Published: (2021-04-01) -
Characterization of pH resistance and the proteolytic activity of GABA producing Lactobacillus brevis BGZLS10-17 in preparation of fermented milk beverage and the effects on the symptoms of the experimental autoimmune encephalomyelitis
by: Soković-Bajić Svetlana S., et al.
Published: (2020-01-01)